FDA NDC Directory · JSON-LD · Markdown

ADAKVEO

NDC 0078-0883 · HUMAN PRESCRIPTION DRUG · INJECTION

Generic namecrizanlizumab
Labeler / ManufacturerNovartis Pharmaceuticals Corporation
Marketing categoryBiologic License Application · App BLA761128
Dosage form / routeINJECTION · INTRAVENOUS
Active ingredientsCRIZANLIZUMAB (10 mg/mL)
Marketing started20191115
Package count1

External sources

Source: openFDA. Public-domain (CC0).